神经系统疾病中的机器学习:一种多变量LSTM和AdaBoost方法来分析阿尔茨海默病的时间序列分析
Muhammad Irfan1, Seyed Shahrestani1, Mahmoud Elkhodr2
1School of Computer, Data and Mathematical Sciences Western Sydney University Sydney Australia.
Health care science
|June 28, 2024
概括
这项研究利用机器学习增强了阿尔茨海默病 (AD) 检测. 多变量长短期记忆 (M-LSTM) 模型实现了82%的准确性,超过了AdaBoost跟踪AD进展的性能.
科学领域:
- 神经科学是一个神经科学.
- 人工智能的人工智能
- 生物医学数据科学 生物医学数据科学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,影响记忆和认知.
- 早期发现AD对于减缓疾病进展至关重要,但也面临诊断挑战.
- 当前的诊断方法往往需要复杂的认知评估和医学测试.
研究的目的:
- 开发和评估先进的机器学习模型,用于早期检测和监测阿尔茨海默病的进展.
- 利用多式联络数据,包括认知评估和神经成像生物标志物.
- 与现有方法相比,提高诊断准确度.
主要方法:
- 实施了一种新的数据采集技术和预处理管道.
- 使用了多变量长短期存储器 (M-LSTM) 和AdaBoost模型.
- 来自认知评估和神经成像扫描的生物标志物使用AD预测纵向进化队列进行了分析.
主要成果:
- 在检测AD进展方面,M-LSTM模型实现了82%的测试准确性.
- 在AdaBoost模型的测试中,测试准确率达到80%.
- 拟议的方法表明,与最近的可比研究相比,准确度显著增加了20%.
结论:
- 多变量M-LSTM模型在识别阿尔茨海默病进展方面表现出卓越的有效性.
- 这种方法为AD监测提供了更准确,潜在的侵入性较小的方法.
- 这些发现突显了先进AI在神经退行性疾病诊断中的潜力.
更多相关视频
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.5K
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
7.9K
相关概念视频
01:26Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461
01:22Alzheimer's Disease: Treatment
178
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
178
01:30Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110